Lv1
30 积分 2023-03-22 加入
Autologous Nanobody-Derived Fratricide-Resistant CD7-CAR T-cell Therapy for Patients with Relapsed and Refractory T-cell Acute Lymphoblastic Leukemia/Lymphoma
17天前
已完结
Autologous CD7 CAR-T cells generated without T cell pre-selection in pediatric patients with relapsed/refractory T-ALL: A phase I trial
18天前
已完结
Preclinical application of a CD155 targeting chimeric antigen receptor T cell therapy for digestive system cancers
19天前
已完结
Evaluation of monoclonal antibodies having specificity for human IgG sub-classes: Results of an IUIS/WHO collaborative study
2个月前
已完结
Evaluation of Thirty-One Mouse Monoclonal Antibodies to Human IgG Epitopes
2个月前
已完结
984 Novel anti-CD3 heavy chain-only antibodies for use in T-cell engaging immunotherapeutics
2个月前
已关闭
抗人转化生长因子β1纳米抗体的制备及功能鉴定
2个月前
已完结
Intraperitoneal administration of carcinoembryonic antigen-directed chimeric antigen receptor T cells is a robust delivery route for effective treatment of peritoneal carcinomatosis from colorectal cancer in pre-clinical study
4个月前
已完结
Hypoxia-Responsive CAR-T Cells Exhibit Reduced Exhaustion and Enhanced Efficacy in Solid Tumors
4个月前
已完结
Hypoxia-responsive CEA-targeted CAR T cells in CEA-positive solid tumors through intraperitoneal or intravenous infusion: a phase 1 trial
4个月前
已完结
皖公网安备34019202002308
